GAGA Share Market News

[hfe_template id='11223'] [ad_1] Indian chemical stocks, including Navin Fluorine, PI Industries, UPL, and SRF, fell by up to 6% in Thursday’s trade after the Trump administration imposed a 26% blanket tariff on Indian imports. The chemicals sector is expected to face a negative impact, with Navin Fluorine (25% revenue exposure), PI Industries (20%), and SRF (7%) directly affected by the higher tariffs. According to Jefferies, the 26% U.S. tariff on the sector could significantly impact revenue streams. Auto stocks were also hit, with Balkrishna Industries, Bharat Forge, Bajaj Auto, Tata Motors, and Motherson falling by up to 4% in response to the announcement. Analysts view this as a major setback for India's export-driven sectors, particularly automobiles. Also Read: Gold, not Bitcoin, is the real threat to the Dollar, says Peter Schiff The automobile sector, which contributes around 3% of India's total exports to the U.S., is expected to face demand pressures....

[hfe_template id='11223'] [ad_1] Brokerage firms have shared their insights and recommendations on three prominent companies, highlighting potential investment opportunities for the next year. Nirmal Bang remains optimistic about Data Patterns, citing strong leadership and robust R&D capabilities, with an 18% upside potential. Jefferies has expressed confidence in PI Industries, despite a target price revision, emphasizing growth prospects driven by new product launches and stable margins, with a 21% upside. Additionally, Jefferies sees significant growth potential in Max Financial Services, supported by rebranding efforts and attractive valuations, projecting a substantial 48% upside. Below is a list of recommendations from top brokerage firms, sourced from ETNow and other platforms: Nirmal Bang on Data Patterns: Maintain Buy, Target Price at Rs 2,997 | LTP Rs 2,541 | Upside 18% Nirmal Bang has maintained a "Buy" rating on Data Patterns, setting a target p...

[hfe_template id='11223'] [ad_1] India’s chemical and petrochemical industry is charting a path towards becoming a global powerhouse, integral to the nation’s economic vision of a USD32 trillion economy. This ambitious journey hinges on a dynamic chemical sector, with manufacturing output projected to increase by an extraordinary 50 times, reaching USD6 trillion. This growth will be driven by strategic partnerships, investments in sustainable practices, and innovation across the chemical value chain. At a recent industry event, experts underscored the critical role of collaboration to advance India's leadership in sustainable chemical solutions. A notable goal is capturing 17% of the global chemical market by 2030, a vision outlined by the Department of Chemicals and Petrochemicals. As part of this plan, India aims to double its chemical exports over the next decade, focusing on emerging fields like bio-plastics, recycling, and environmental sustainability. These eff...

[hfe_template id='11223'] [ad_1] "We see the risk of an imminent 5-10% correction in the headline indices, with bigger drawdowns in small and midcap stocks. Nifty valuations are stretched at 21.4x 1YF PER, and a positive budget is now in the price. There are no additional positive catalysts, as we expect a tepid 1QFY25 earnings season with rate cuts coming only at end-CY24," Seshadri Sen, Head Of Research, Emkay Global, said in a note to investors. He said a sell-off is likely to be led by Industrials (high valuations) and financials (most liquid), but durables like autos are vulnerable too. "The best places to hide are staples, energy, and technology, in that order. We remain constructive on India from a longer-term (>1 year) perspective, and would use a meaningful correction to increase exposure to the market," Sen said. In the Union Budget, which will be presented in the Parliament on Tuesday, Nirmala Sitharaman is widely expected to tread the p...

[hfe_template id='11223'] [ad_1] Brokerage firms such as Jefferies maintained an underperform rating on Dr Reddy’s Laboratories, Equirus recommended a Long on PI Industries, Morgan Stanley initiated coverage on Go Digit with an Equal Weight rating and Jefferies has a hold rating on Bharti Hexacom. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Jefferies on Dr Reddy’s Laboratories: Underperform | Target Rs 5010 Jefferies maintained an underperform rating on Dr Reddy’s Laboratories with a target price of Rs 5,010. Growth of acquired brands has remained stagnant in recent years and will require upfront investments. The potential impact of synergies from the acquired portfolio should start reflecting only over FY27-28. The acquisition is for GBP500m implying 2.3x sales, ~9x EV-Ebitda on CY23 numbers.Dr Reddy expects the deal to be margin accretive and remains confident of achieving 25% Ebitda margin on a consolidated basis. ...